⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for pharmacokinetics (pk)

Every month we try and update this database with for pharmacokinetics (pk) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate CancerNCT02705469
Metastatic Cast...
ZEN003694
18 Years - Zenith Epigenetics
Study to Describe the Interaction Between Tazemetostat and Itraconazole and Between Tazemetostat and Rifampin in Participants With Advanced CancerNCT04537715
All Malignancie...
Advanced Malign...
Hematologic Mal...
Solid Tumor
Follicular Lymp...
Non-Hodgkin Lym...
Diffuse Large B...
Epithelioid Sar...
Synovial Sarcom...
Renal Medullary...
Mesothelioma
Rhabdoid Tumor
Tazemetostat
Itraconazole
Tazemetostat
Rifampin
18 Years - Ipsen
Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)NCT00444015
Non-Small-Cell ...
Erlotinib in co...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: